Molecular diagnosis of medical viruses.

The diagnosis of infectious diseases has been revolutionized by the development of molecular techniques, foremost with the applications of the polymerase chain reaction (PCR). The achievable high sensitivity and ease with which the method can be used to detect any known genetic sequence have led to its wide application in the life sciences. More recently, real-time PCR assays have provided additional major contributions, with the inclusion of an additional fluorescent probe detection system resulting in an increase in sensitivity over conventional PCR, the ability to confirm the amplification product and to quantitate the target concentration. Further, nucleotide sequence analysis of the amplification products has facilitated epidemiological studies of infectious disease outbreaks, and the monitoring of treatment outcomes for infections, in particular with viruses which mutate at high frequency. This review discusses the applications of qualitative and quantitative real-time PCR, nested PCR, multiplex PCR, nucleotide sequence analysis of amplified products and quality assurance with nucleic acid testing (NAT) in diagnostic laboratories.

[1]  R. Ratcliff,et al.  Sensitive Detection of RNA Viruses Associated with Gastroenteritis by a Hanging-Drop Single-Tube Nested Reverse Transcription-PCR Method , 2002, Journal of Clinical Microbiology.

[2]  T. Nakano,et al.  Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response , 2005, Gut.

[3]  Thomas F. Smith,et al.  Diagnosis of Herpes Simplex Virus Infections in the Clinical Laboratory by LightCycler PCR , 2000, Journal of Clinical Microbiology.

[4]  X. Jiang,et al.  Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR. , 1999, Journal of virological methods.

[5]  J. Vinjé,et al.  Development and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup I and II noroviruses. , 2004, Journal of virological methods.

[6]  W. Al-Soud,et al.  Purification and Characterization of PCR-Inhibitory Components in Blood Cells , 2001, Journal of Clinical Microbiology.

[7]  R. Abramson,et al.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Roger I Glass,et al.  Norovirus classification and proposed strain nomenclature. , 2006, Virology.

[9]  J. Bates,et al.  A new confirmatory Neisseria gonorrhoeae real-time PCR assay targeting the porA pseudogene , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[10]  D. Whiley,et al.  Detection of Human Respiratory Syncytial Virus in Respiratory Samples by LightCycler Reverse Transcriptase PCR , 2002, Journal of Clinical Microbiology.

[11]  D. Richman The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B , 2000, Hepatology.

[12]  M. Hiyoshi,et al.  Assay of DNA denaturation by polymerase chain reaction-driven fluorescent label incorporation and fluorescence resonance energy transfer. , 1994, Analytical biochemistry.

[13]  R. Glass,et al.  The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. , 2000, The Journal of infectious diseases.

[14]  M. Boeckh,et al.  Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications , 1998, Clinical Microbiology Reviews.

[15]  D. Pillay,et al.  Transmission of HIV-1 drug resistance. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  D. Whiley,et al.  Detection and Differentiation of Human Polyomaviruses JC and BK by LightCycler PCR , 2001, Journal of Clinical Microbiology.

[17]  D. Richman,et al.  Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region , 2001, Hepatology.

[18]  M. Malim,et al.  A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration , 2002, Journal of Virology.

[19]  M. Mhlanga,et al.  Using molecular beacons to detect single-nucleotide polymorphisms with real-time PCR. , 2001, Methods.

[20]  J. Schapiro,et al.  Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial , 1999, The Lancet.

[21]  A. Simmons Clinical manifestations and treatment considerations of herpes simplex virus infection. , 2002, The Journal of infectious diseases.

[22]  C. Gibbs,et al.  In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance , 2000, Hepatology.

[23]  R. Glass,et al.  Correlation of patient immune responses with genetically characterized small round‐structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995 , 1997, Journal of medical virology.

[24]  Andrea Scozzafava,et al.  Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. , 2005, Current pharmaceutical design.

[25]  Lidia Ruiz,et al.  Clinical utility of HIV-1 genotyping and expert advice: the Havana trial , 2002, AIDS.

[26]  U J Balis,et al.  The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. , 1997, BioTechniques.

[27]  S. Chou,et al.  How Evolution of Mutations Conferring Drug Resistance Affects Viral Dynamics and Clinical Outcomes of Cytomegalovirus-Infected Hematopoietic Cell Transplant Recipients , 2005, Journal of Clinical Microbiology.

[28]  Victoria A Johnson,et al.  Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Y. Shiratori,et al.  YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitrofull‐length viral DNA transfection , 1999, Hepatology.

[30]  D. Ho,et al.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.

[31]  S. Chou,et al.  Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. , 2003, The Journal of infectious diseases.

[32]  D. Whiley,et al.  Sequence variation in primer targets affects the accuracy of viral quantitative PCR. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[33]  Michael Ames,et al.  A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy , 2002, AIDS.

[34]  D. L. Crombie,et al.  The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis , 1965, Proceedings of the Royal Society of Medicine.

[35]  Amalio Telenti,et al.  Update of the Drug Resistance Mutations in HIV-1: 2005. , 2005, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[36]  J. Stephenson The art of 'HAART': researchers probe the potential and limits of aggressive HIV treatments. , 1997, JAMA.

[37]  J. Wands,et al.  Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective , 1998, Hepatology.

[38]  S. Koh,et al.  Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the 'a' epitope of the surface antigen are sensitive to ganciclovir. , 1999, Antiviral research.

[39]  W. Al-Soud,et al.  Characterization of the PCR inhibitory effect of bile to optimize real-time PCR detection of Helicobacter species. , 2005, FEMS immunology and medical microbiology.

[40]  J. Kahn,et al.  Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. , 1998, The New England journal of medicine.

[41]  W. Carpay,et al.  Principles of quantitation of viral loads using nucleic acid sequence-based amplification in combination with homogeneous detection using molecular beacons. , 2002, Nucleic acids research.

[42]  Raman Kumar,et al.  Evaluation of PCR-based methods for the quantitation of integrated HIV-1 DNA. , 2002, Journal of virological methods.

[43]  E. Lukhtanov,et al.  3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. , 2000, Nucleic acids research.

[44]  F. McCutchan,et al.  Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. , 1993, The New England journal of medicine.

[45]  A. Falsey,et al.  Respiratory syncytial virus and influenza A infections in the hospitalized elderly. , 1995, The Journal of infectious diseases.

[46]  T. Merigan,et al.  A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy , 2000 .

[47]  Ian N. Clarke,et al.  Norwalk-like viruses , 2002 .

[48]  M. Cambra,et al.  New device and method for capture, reverse transcription and nested PCR in a single closed-tube. , 1999, Nucleic acids research.

[49]  D. Whiley,et al.  A 5'-nuclease real-time reverse transcriptase-polymerase chain reaction assay for the detection of a broad range of influenza A subtypes, including H5N1. , 2005, Diagnostic microbiology and infectious disease.

[50]  D. Richman,et al.  Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples. , 1998, AIDS Research and Human Retroviruses.

[51]  G. Boivin,et al.  Discordant phenotypes and genotypes of Cytomegalovirus (CMV) in patients with AIDS and relapsing CMV retinitis , 2003, AIDS.

[52]  Roger I Glass,et al.  Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. , 2002, The Journal of infectious diseases.

[53]  S. Fukushi,et al.  Genogroup-specific PCR primers for detection of Norwalk-like viruses. , 2002, Journal of virological methods.

[54]  C. R. Connell,et al.  Allelic discrimination by nick-translation PCR with fluorogenic probes. , 1993, Nucleic acids research.

[55]  K. Livak,et al.  Real time quantitative PCR. , 1996, Genome research.

[56]  R A Gibbs,et al.  Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. , 1988, Nucleic acids research.

[57]  D. Coen Viral DNA Polymerases , 1996 .

[58]  G. Opdenakker,et al.  Evaluating phenotype and genotype of drug-resistant strains in herpesviruses , 2001, Molecular biotechnology.

[59]  C. Saint,et al.  Comparison of SYTO9 and SYBR Green I for real-time polymerase chain reaction and investigation of the effect of dye concentration on amplification and DNA melting curve analysis. , 2005, Analytical biochemistry.

[60]  R. P. Bucy,et al.  Quantitation of HIV-1 by real-time PCR with a unique fluorogenic probe. , 2001, Journal of virological methods.

[61]  H. Doerr,et al.  Human Immunodeficiency Virus and Hepatitis B Virus Infection in Pregnancy: Diagnostic Potential of Viral Genome Detection , 1999, Intervirology.

[62]  C. Romero-Lopez,et al.  Inhibition of HIV-1 replication by RNA targeted against the LTR region , 2005, AIDS.

[63]  K. Kleesiek,et al.  Single-tube nested PCR with room-temperature-stable reagents. , 1995, PCR methods and applications.

[64]  T. Kok,et al.  Comparison of six nucleic acid extraction methods for detection of viral DNA or RNA sequences in four different non-serum specimen types. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[65]  A. Nitsche,et al.  Detection and subtyping of Herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture , 2002, BMC Microbiology.

[66]  D. Bernstein,et al.  Detection of varicella-zoster virus DNA in nasopharyngeal secretions of immune household contacts of varicella. , 1993, The Journal of infectious diseases.

[67]  R. Buckheit Understanding HIV resistance, fitness, replication capacity and compensation: targeting viral fitness as a therapeutic strategy. , 2004, Expert opinion on investigational drugs.

[68]  B Roizman,et al.  Herpes simplex viruses. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[69]  Respiratory syncytial virus infection: admissions to hospital in industrial, urban, and rural areas. Report to the Medical Research Council Subcommittee on Respiratory Syncytial Virus Vaccines. , 1978, British medical journal.

[70]  D. Tyrrell,et al.  Mutation in HBV RNA‐dependent DNA polymerase confers resistance to lamivudine in vivo , 1996, Hepatology.

[71]  C. Yurdaydın,et al.  A novel pattern (sW195a) in surface gene of HBV DNA due to YSDD (L180M plus M204S) mutation selected during lamivudine therapy and successful treatment with adefovir dipivoxil. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[72]  K. Livak,et al.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. , 1995, PCR methods and applications.

[73]  B. Stone,et al.  Rapid detection and simultaneous subtype differentiation of influenza A viruses by real time PCR. , 2004, Journal of virological methods.

[74]  影山 努 Broadly Reactive and Highly Sensitive Assay for Norwalk-Like Viruses Based on Real Time Quantitative Reverse Transcription-PCR , 2004 .

[75]  Roger I. Glass,et al.  Use of TaqMan Real-Time Reverse Transcription-PCR for Rapid Detection, Quantification, and Typing of Norovirus , 2006, Journal of Clinical Microbiology.

[76]  M. Kubista,et al.  Detection of PCR products in real time using light-up probes. , 2000, Analytical biochemistry.

[77]  Hope-Simpson Re THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. , 1965 .

[78]  W. P. Glezen,et al.  Risk of primary infection and reinfection with respiratory syncytial virus. , 1986, American journal of diseases of children.

[79]  P. Rådström,et al.  Effects of Amplification Facilitators on Diagnostic PCR in the Presence of Blood, Feces, and Meat , 2000, Journal of Clinical Microbiology.

[80]  T. Ando,et al.  Genetic classification of "Norwalk-like viruses.. , 2000, The Journal of infectious diseases.

[81]  P. Bernard,et al.  Integrated amplification and detection of the C677T point mutation in the methylenetetrahydrofolate reductase gene by fluorescence resonance energy transfer and probe melting curves. , 1998, Analytical biochemistry.

[82]  D. Whiley,et al.  Melting curve analysis using hybridisation probes: limitations in microbial molecular diagnostics. , 2005, Pathology (Sydney).

[83]  S. Staszewski,et al.  Comparison of Nine Resistance Interpretation Systems for HIV-1 Genotyping , 2002, Antiviral therapy.

[84]  R. MacArthur An updated guide to genotype interpretation. , 2004, The AIDS reader.

[85]  R. Zeillinger,et al.  Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain. , 1995, PCR methods and applications.

[86]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[87]  G. Lucas Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. , 2005, The Journal of antimicrobial chemotherapy.

[88]  M. Isaacs,et al.  Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations , 2004, Journal of medical virology.

[89]  C. Wittwer,et al.  Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. , 1997, Clinical chemistry.

[90]  M. Wharton,et al.  The epidemiology of varicella-zoster virus infections. , 1996, Infectious disease clinics of North America.

[91]  J. Lieberman,et al.  The prospect of silencing disease using RNA interference. , 2005, JAMA.

[92]  D. Whiley,et al.  Detection and differentiation of herpes simplex virus types 1 and 2 by a duplex LightCycler PCR that incorporates an internal control PCR reaction. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[93]  G. Nolan,et al.  Gene therapy progress and prospects: Novel gene therapy approaches for AIDS , 2005, Gene Therapy.